Advisory Board March 25, 2024

CMS on Thursday announced that Medicare Part D drug benefit plans can cover weight-loss drugs for patients who have a history of heart disease and are using the drugs to prevent heart attacks and strokes.

Related: Wegovy’s benefits are real, but access remains an issue

Medicare will cover certain weight-loss drugs

Currently, federal law prevents Medicare Part D plans from covering obesity medications for weight loss alone. However, CMS’ new guidance states that Medicare Part D plans can cover anti-obesity medications provided the drugs receive approval for “an additional medically accepted indication.”

“For example, a drug that receives FDA approval for chronic weight management alone would not be considered a Part D drug,” CMS said. “[But] if this same drug...

Today's Sponsors

LEK
ZeOmega

Today's Sponsor

LEK

 
Topics: Biotechnology, CMS, Govt Agencies, Insurance, Medicare, Patient / Consumer, Pharma / Biotech, Provider
109 hospitals receiving new Medicare-backed residency slots
Senators urge Congress to avert Medicare physician pay cut
Podcast: Medicare Shared Savings Program Mints $2B Win for Value-Based Care w/ Frank McStay
Medicare Part D in 2025: A First Look at Prescription Drug Plan Availability, Premiums, and Cost Sharing
Dr. Oz, RFK Jr. on Medicare, Medicaid: 10 notes

Share This Article